Innovative Biologics Platform Zea Biosciences utilizes proprietary technology for plant-based biologics production, presenting opportunities to collaborate with pharmaceutical companies seeking sustainable, scalable biologic solutions derived from natural sources.

Strategic Academic Partnerships Recent licensing agreements with top research institutions like the University of Pennsylvania open avenues for partnership with biotech and academic organizations interested in cutting-edge biologics and vaccine development.

Recognition & Credibility Being a finalist in Fast Company's World Changing Ideas highlights Zea's innovative approach and market credibility, making it an attractive partner for investors and companies seeking disruptive solutions in biotech.

Niche Market Focus Operate in a high-growth, $400 billion market with opportunities to target pharmaceutical companies, wellness brands, and biotech firms looking for plant-based medicinal products to expand their product portfolios.

Technology & Data Analytics Leveraging advanced analytics and diverse tech stack, Zea can offer tailored biologic solutions and data-driven insights to biotech firms aiming to optimize plant-based drug manufacturing and research processes.